Alta Life Sciences
Overview
Alta Life Sciences is a leading multistage venture capital investment firm that identifies breakthrough scientific discoveries that solve unmet medical needs in all areas of life sciences, including biotechnology, medical devices, diagnostics, genomics and digital health, and invests seeking both the highest societal impact and the greatest potential returns . The firm invests in companies at all stages of development, from seed financing through commercial growth .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ona Therapeutics | Jun 2026 | Series B | Co-investor |
| Peptomyc | Mar 2024 | VC Round | Lead |
| Deepull | Mar 2023 | Series B Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Alta Life Sciences based?
Alta Life Sciences is headquartered in Spain.
When was Alta Life Sciences founded?
Alta Life Sciences was founded in 2016.
How many portfolio companies does Alta Life Sciences have?
Alta Life Sciences has 8 portfolio companies in Caplight's dataset.
What are some companies in Alta Life Sciences's portfolio?
Recent investments visible on Caplight include Ona Therapeutics, Ona Therapeutics, Peptomyc, Deepull, Deepull.
What was Alta Life Sciences's most recent investment?
Alta Life Sciences's most recent investment on Caplight was in Ona Therapeutics in 2026.
What sectors does Alta Life Sciences focus on?
Alta Life Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Alta Life Sciences focus on?
Alta Life Sciences typically invests at the MultiStage stage.
What is Alta Life Sciences's AUM?
Alta Life Sciences's assets under management are estimated between $100.0M and $250.0M.